Page last updated: 2024-10-31

acecainide and Arteriosclerosis

acecainide has been researched along with Arteriosclerosis in 1 studies

Acecainide: A major metabolite of PROCAINAMIDE. Its anti-arrhythmic action may cause cardiac toxicity in kidney failure.
N-acetylprocainamide : A benzamide obtained via formal condensation of 4-acetamidobenzoic acid and 2-(diethylamino)ethylamine.

Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.

Research Excerpts

ExcerptRelevanceReference
" The mean half-life of elimination after a single 500 mg dose of acecainide was 7."2.65Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide. ( Higgins, SB; Oates, JA; Reele, SB; Roden, DM; Smith, RF; Wilkinson, GR; Woosley, RL, 1980)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Roden, DM1
Reele, SB1
Higgins, SB1
Wilkinson, GR1
Smith, RF1
Oates, JA1
Woosley, RL1

Trials

1 trial available for acecainide and Arteriosclerosis

ArticleYear
Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.
    The American journal of cardiology, 1980, Volume: 46, Issue:3

    Topics: Acecainide; Adolescent; Adult; Aged; Ambulatory Care; Anti-Arrhythmia Agents; Arrhythmias, Cardiac;

1980